Skip to main content

Peer Review reports

From: Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol

Original Submission
28 Oct 2022 Submitted Original manuscript
25 Nov 2022 Reviewed Reviewer Report - Riaz Qureshi
12 Dec 2022 Author responded Author comments - Despina Eleftheriou
Resubmission - Version 2
12 Dec 2022 Submitted Manuscript version 2
20 Dec 2022 Reviewed Reviewer Report - Riaz Qureshi
Resubmission - Version 3
Submitted Manuscript version 3
23 Dec 2022 Editorially accepted
26 Jan 2023 Article published 10.1186/s13063-022-07051-9

You can find further information about peer review here.

Back to article page